Keywords: positive, results, merrion, osteoporosis, drug, pharmaceuticals, dublin

Positive results for Merrion's osteoporosis drug

Article | 22 January 2007

Merrion Pharmaceuticals, a Dublin, Ireland-headquartered specialty pharmaceutical company, has successfully completed a clinical pharmacology study of MER 103, a novel oral ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Merck

Merck KGaA

Go to company listing

Related Drugs

Alendronate Sodium

Fosamax

Nystatin

Go to drug listing